MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

From Campotomy to MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson’s: A Systematic Review in the Context of a Phase III Study

C. Ferrer, A. Sanchez Fraga, L. Knight, R. Martuscello, K. Gant, A. Leruste, A. Grinspan (Munich, Germany)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Stereotactic neurosurgery

Category: Parkinson's Disease: Surgical Therapy

Objective: To summarize and review efficacy and safety evidence of pallidothalamic tractotomy (PTT) using MR-guided focused ultrasound (MRgFUS).

Background: Speigel and Wycis performed lesions in the Forel field and introduced the term “campotomy” to describe the procedure​1​ . Since then, this approach has seen a revival with PTT-MRgFUS​2​  and is being investigated as an incisionless therapy for Parkinson’s disease (PD)​3​ . A Phase III trial (NCT04728295) of staged-bilateral PTT-MRgFUS has been completed, and 12-month follow-up data are under FDA review. This systematic literature review (SLR) aims to assess the published evidence to help contextualize these upcoming results.

Method: An SLR was conducted via Medline and Medline In-Process, with no date limits (Table 1). Two reviewers independently screened titles and abstracts. Full-text review, data extraction, and narrative synthesis followed.

Results: All reports were single-center studies conducted in Switzerland (5)​4–7​ , Taiwan (2)​8,9​ , and Japan (1)​10​  (Figure 1). Unilateral PTT-MRgFUS (n=102) was an effective treatment, demonstrating statistically significant outcomes in all studies. Improvements were as high as (84%) reductions in tremor, (70%) rigidity, (73%) bradykinesia, (67%) off-medication dystonia and (38%) on-medication dyskinesias. Two staged-bilateral studies (n=25) had a mean interval of 20±10 months between the first and second PTT-MRgFUS treatments. Total off-medication UPDRS scores decreased by 52% (p<0.007). Findings on reductions in L-Dopa intake were mixed. The most common adverse events included hypoesthesia, speech difficulties, hiccups. In all the studies, no PTT related serious adverse events were reported. Recently, a modified approach was introduced by Chen et al., incorporating a dual-target VIM-PTT strategy.

Conclusion: This SLR shows PTT-MRgFUS effectively reduces motor symptoms and complications with a generally favorable safety profile. The Phase III study could expand bilateral treatment for idiopathic PD, as the first global multicenter trial investigating unilateral and staged-bilateral PTT-MRgFUS. Emerging targeting strategies highlight the need for further research to refine the optimal target, conduct larger confirmatory trials, and improve patient selection.

Inclusion and exclusion criteria

Inclusion and exclusion criteria

PRISMA study selection flowchart

PRISMA study selection flowchart

References: 1. Spiegel, E. A. et al. Campotomy in Various Extrapyramidal Disorders. J. Neurosurg. 20, 871–884 (1963).
2. Guridi, J. & Gonzalez-Quarante, L. H. REVISITING FOREL FIELD SURGERY. World Neurosurg 147, 11–22 (2020).
3. Gallay, M. N., Jeanmonod, D., Liu, J. & Morel, A. Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgery. Brain Struct Funct 212, 443–463 (2008).
4. Gallay, M. N., Moser, D., Magara, A. E., Haufler, F. & Jeanmonod, D. Bilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson’s Disease With 1-Year Follow-Up. Front Neurol 12, 601153 (2021).
5. Magara, A. et al. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease. J Ther Ultrasound 2, 11 (2014).
6. Gallay, M. N. et al. MRgFUS Pallidothalamic Tractotomy for Chronic Therapy-Resistant Parkinson’s Disease in 51 Consecutive Patients: Single Center Experience. Frontiers Surg 6, 76 (2020).
7. Gallay, M. N., Moser, D., Federau, C. & Jeanmonod, D. Radiological and Thermal Dose Correlations in Pallidothalamic Tractotomy With MRgFUS. Frontiers Surg 6, 28 (2019).
8. Chen, J., Chen, C., Aoh, Y., Lu, M. & Tsai, C. Stepwise dual‐target magnetic resonance‐guided focused ultrasound in tremor‐dominant Parkinson disease: One‐year follow‐up. Eur. J. Neurol. 31, e16468 (2024).
9. Chen, J.-C., Lu, M.-K., Chen, C.-M. & Tsai, C.-H. Stepwise Dual-target MR-guided Focused Ultrasound in Tremor-dominant Parkinson’s Disease: a Feasibility Study. World Neurosurg (2022) doi:10.1016/j.wneu.2022.12.049.
10. Horisawa, S. et al. Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson’s disease: a prospective open-label study. J Neurosurg 135, 799–805 (2021).

To cite this abstract in AMA style:

C. Ferrer, A. Sanchez Fraga, L. Knight, R. Martuscello, K. Gant, A. Leruste, A. Grinspan. From Campotomy to MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson’s: A Systematic Review in the Context of a Phase III Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/from-campotomy-to-mr-guided-focused-ultrasound-pallidothalamic-tractotomy-for-parkinsons-a-systematic-review-in-the-context-of-a-phase-iii-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/from-campotomy-to-mr-guided-focused-ultrasound-pallidothalamic-tractotomy-for-parkinsons-a-systematic-review-in-the-context-of-a-phase-iii-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley